Bioinformatics Market to Grow with a CAGR of 12.34% through 2030
Increased demand for
personalized medicine and increasing bioinformatics funding from the public and
private sectors is expected to drive the Global Bioinformatics Market growth in
the forecast period, 2026-2030.
According to TechSci Research
report, “Bioinformatics Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2030F”, the Global Bioinformatics
Market stood at USD 11.24 billion in 2024 and is anticipated to grow with a
CAGR of 12.34% in the forecast period through 2030. The growth of personalized
medicine, drug discovery, precision agriculture, synthetic biology, and
environmental biotechnology are pivotal factors driving the Bioinformatics
Market. Advancements in AI, data
integration, and ethical considerations are poised to enhance the impact of
bioinformatics on healthcare, agriculture, and the environment, positioning it
as a compelling investment opportunity with significant social and scientific
implications. Advanced genomic sequencing technologies, such as NGS, have
substantially reduced the cost of sequential studies while providing
high-variant detection power and sensitivity through multiple sequencing
capabilities. For instance, NGS enables the determination of millions of
fragments per run, delivering cost benefits by eliminating the need for
multiple sequencing cycles. Factors such as the advent of NGS, DNA microarray, and CRISPR have brought about a paradigm shift in genomic sequencing and editing procedures. These advancements enable targeted and high-throughput sequencing and multiplexing, driving the growth of the bioinformatics market during the forecast period.
The development of sophisticated bioinformatics tools for NGS is an emerging trend that influences market growth. Oxford Nanopore MinION, a key bioinformatics tool used for DNA sequencing, facilitates real-time, on-site DNA sequencing and aids in the identification of virus mutations and tracking their evolutionary history. While DNA sequencing technologies have rapidly evolved and robust commercial platforms have become more accessible, analyzing the data obtained through NGS remains a significant challenge. To address this, various companies now offer commercial solutions for NGS, alleviating issues associated with data analysis scale and the need for command-line computer languages. These trends contribute to the market's growth during the forecast period.
The growth of the global bioinformatics market is primarily driven by data and technological advancements in the field, improving the quality of services provided. Many nations are investing in national population sequencing initiatives to better understand the connection between genetics and diseases. Public and commercial institutions worldwide are also making steady investments in bioinformatics. As cutting-edge NGS technology becomes more prevalent, there is an increasing demand for efficient, rapid, and accurate bioinformatics tools.
Bioinformaticians constitute a small majority of scientists involved in experimental inquiry, emphasizing the importance of user-friendly tools for bioinformatics platforms. However, many existing bioinformatics programs lack appropriate user interfaces, often requiring significant computer knowledge. In the coming years, the rising significance of emerging economies in terms of research and development, along with investments from international companies, is expected to offer a positive outlook and opportunities for the growth of genomics, metabolomics, precision medicine, drug discovery, and other related markets.
The rapid development of next-generation sequencing technology has generated a significant amount of biological data, and this volume continues to grow with increased usage of NGS. Effective data analysis is crucial due to the extensive material available for genomic analysis. Consequently, the residual data after bioinformatics analysis holds great value and can be repurposed. However, challenges in data management within bioinformatics are not adequately addressed by existing solutions. Additionally, a lack of skilled personnel, common data formats, and the absence of affordable user-friendly tools are projected to hinder market development during the forecast period.
To maintain their market positions and introduce new products globally, major players in the bioinformatics market employ various strategies, such as collaborations and acquisitions with other organizations. These key market players collaborate to develop next-generation sequencing-based assays that assess cancer-relevant genetic changes using RNA and DNA derived from a patient's tumor in a single process. Furthermore, the release of technologically advanced bioinformatics tools and software, such as AUTODOCK, BALL, and RasMol, combined with increased market utilization of these tools for accurate and precise analysis of biomarkers discovery programs, is expected to propel the growth of the global bioinformatics market.
Browse over XX market data
Figures spread through XX Pages and an in-depth TOC on "Global
Bioinformatics Market.”
Global Bioinformatics Market
is segmented into product & services, type, application, end user, regional
distribution, and company
Based on type, the genomics and proteomics segment is experiencing the fastest growth in the bioinformatics market. This growth is driven by the increasing use of bioinformatics tools in analyzing large-scale genetic and protein data. Genomics plays a vital role in understanding genetic variations and their links to diseases, which supports advancements in personalized medicine and diagnostics. At the same time, proteomics helps in studying protein structures and functions, aiding in drug discovery and disease pathway analysis. The rising adoption of next-generation sequencing, advancements in data analysis technologies, and growing investments in life sciences research are further accelerating the demand for bioinformatics in these areas. As a result, genomics and proteomics are emerging as key drivers of growth within the bioinformatics market.
Based on region, Asia Pacific is witnessing the fastest growth in the global bioinformatics market. This rapid expansion is driven by increasing investments in biotechnology research, growing adoption of advanced genomic technologies, and supportive government initiatives aimed at strengthening healthcare and life sciences infrastructure. Countries such as China, India, and Japan are at the forefront, with rising demand for personalized medicine, next-generation sequencing, and data-driven drug discovery. Additionally, improvements in digital infrastructure and increased collaboration between research institutions and biotech companies are further fueling the market's growth in the region. As a result, Asia Pacific is emerging as the most dynamic and rapidly advancing region in the bioinformatics space.
Major companies operating in
Global Bioinformatics Market are:
- 3rd Millennium Inc.
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- BioWisdom Ltd
- Quest Diagnostics (Celera
Corporation)
- Dassault Systèmes SE
- Illumina, Inc.
- Geneva Bioinformatics SA
- Perkin Elmer, Inc.
- Lineage Cell Therapeutics (BioTime
Inc.)
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“The global market is primarily
driven by significant advancements in the field of biotechnology. Concurrently,
the growing demand for nucleic acid and protein sequencing for proteomics and
drug discovery contributes to market growth. The data and information collected
aid in understanding the molecular mechanisms of diseases, facilitating the
development of more efficient diagnostic tests and treatment methods. Moreover,
the widespread adoption of bioinformatics in the agriculture sector propels
market growth by studying the genetic, proteomic, and phenome information of
seeds to improve crop productivity. Additionally, technological advancements
such as the integration of artificial intelligence (AI) and big data technology
in the healthcare sector drive the demand for this technology. Increasing
investments by IT companies for bioinformatics solutions and the rising
preference for personalized medicines globally are expected to further drive
the market.,” said Mr. Karan Chechi, Research Director of TechSci Research, a
research-based management consulting firm.
“Bioinformatics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Services (Bioinformatics Tools, Bioinformatic Platforms and Bioinformatic Services), By Type (Genomics & Proteomics, Simulation Studies & Molecular Modelling, Genetic Engineering, Others), By Application (Metagenomics, Drug Discovery, Precision Medicine, Others), By End User (Institutional Research, Industrial Research), By Region and Competition, 2020-2030F”, has evaluated the future growth
potential of Global Bioinformatics Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Bioinformatics Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com